Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

• Κύριοι συγγραφείς: Costanza Di Chiara (Συγγραφέας), Daniele Mengato (Συγγραφέας), Marica De Pieri (Συγγραφέας), Germana Longo (Συγγραφέας), Elisa Benetti (Συγγραφέας), Francesca Venturini (Συγγραφέας), Carlo Giaquinto (Συγγραφέας), Daniele Donà (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-03-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...